Show simple item record

dc.contributor.authorDening, Tom
dc.date.accessioned2017-09-06T12:43:37Z
dc.date.available2017-09-06T12:43:37Z
dc.date.issued2013
dc.identifier.citationFox, C., Lafortune, L., Boustani, M., Dening, T., Rait, G. & Brayne, C. (2013). Screening for dementia - Is it a no brainer? International Journal of Clinical Practice, 67 (11), pp.1076-1080.
dc.identifier.other10.1111/ijcp.12239
dc.identifier.urihttp://hdl.handle.net/20.500.12904/7922
dc.description.abstractAs people are living longer, dementia is becoming a significant issue for society. Dementia is now recognised as a major concern in society, and the numbers of people estimated to have dementia in the UK population appear to have stabilised at around 700,000. Globally, 35.6 million people are estimated to meet criteria for dementia, a number predicted to double every 20 years. Given the absence of treatments that significantly alter the natural history of the clinical syndrome of dementia, there has been increased emphasis on early diagnosis, with research exploring assessment tools and biomarkers that might predict with certainty a particular clinical outcome. At the same time, there has been pressure to focus on biomedical profiles, which assume a very close link between the pathobiology and the manifest clinical syndrome. © 2013 John Wiley & Sons Ltd.
dc.description.urihttp://onlinelibrary.wiley.com/doi/10.1111/ijcp.12239/epdf
dc.subjectDementia
dc.titleScreening for dementia - Is it a no brainer?
dc.typeArticle
html.description.abstractAs people are living longer, dementia is becoming a significant issue for society. Dementia is now recognised as a major concern in society, and the numbers of people estimated to have dementia in the UK population appear to have stabilised at around 700,000. Globally, 35.6 million people are estimated to meet criteria for dementia, a number predicted to double every 20 years. Given the absence of treatments that significantly alter the natural history of the clinical syndrome of dementia, there has been increased emphasis on early diagnosis, with research exploring assessment tools and biomarkers that might predict with certainty a particular clinical outcome. At the same time, there has been pressure to focus on biomedical profiles, which assume a very close link between the pathobiology and the manifest clinical syndrome. © 2013 John Wiley & Sons Ltd.


This item appears in the following Collection(s)

Show simple item record